Vaccine & Infectious Disease CRO Solutions

Offering global CRO services in support of clinical research for emerging and re-emerging diseases.

Learn More About COVID-19 Services

Wide-Ranging Infectious Disease & Vaccine Expertise

Infectious Disease & Vaccine By The Numbers

NUMBER OF STUDIES

NUMBER OF PATIENTS

NUMBER OF SITES

It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Our teams have executed studies for infectious disease and vaccine treatments across a wide variety of indications:

Abdominal infections

Bronchiectasis

C. difficile

Cellulitis

Common cold

COVID-19

Hepatitis B

Hepatitis C

HIV

Impetigo

Influenza

Intra-abdominal infection

Otitis media

Pneumonia

Prosthetic joint infection

RSV

Sepsis/septic shock

Skin structure infection

Tinea pedis

Traveler's diarrhea

Tuberculosis

Upper respiratory tract infection

Urinary tract infection

Request a Proposal

Global Infectious Disease & Vaccine Expertise

US Government Federal Research

We have supported federally-funded research for more than 20 years. We can support your organization's effort to secure government funding. Our proven track record has allowed us to collaborate on over $778M in government-funded trials with several agencies including the NIH, DOD, BARDA, and CDC.

Learn More

Expeditionary CRO

As an infectious disease CRO and vaccine CRO, we often have to bring our clinical research efforts to the patients where they are. Our Expeditionary capabilities allow us to add over 30 additional countries to our global coverage. We leverage our staff with strategically-advantageous site relationships and partner networks to reach patients in remote regions.

Learn More

Emerging/Re-emerging

Today it's the coronavirus COVID-19. Tomorrow, it will be something else. Pharm-Olam maintains staff with deep expertise in infectious diseases and vaccines. Roughly 84% of PMs and 79% of CRAs have ID&V expertise. We are ready to go the distance to support finding new vaccines and therapeutics.

Antibiotic CRO Legacy

As an Infectious Disease CRO, we have deep roots in supporting anti-infective development. Our long and successful history in the anti-infective area of drug development is demonstrated by supporting more than 50% of all NCE antibiotics approved by FDA since 2013.

Sponsor Testimonial

“Working with Pharm-Olam was an absolute pleasure. The entire team was very knowledgeable, professional and customer focused. They showed an excellent level of organization and were always on top of any issues.”

Biotech - Director ClinOps

Pharm-Olam Supporting COVID-19 Research

Pharm-Olam stands with the global community and the fight against COVID-19. No other disease in recent history has captured the world like Coronavirus. As an Infectious Disease and Vaccine CRO, we are poised to help pharmaceutical and biotechs by rapidly deploying their clinical trials in the search for vaccines and therapies to fight this infectious disease. Together, we can create a healthier world.

Our Participation in OWS

We have several on-going COVID-19 studies and are proud to have been selected by the US Department of Defense as a CRO prime contractor in support of Operation Warp Speed.

Learn about OWS

COVID-19 CRO Services

We understand that drug development partners with medical countermeasures (MCM) expertise are crucial in bringing vaccines and treatments to the front lines of the COVID-19 battle. As an MCM-capable CRO, Pharm-Olam is ready to go the distance in supporting those studies.

Learn About Our COVID-19 Services

Seeking Government Funding for Your Project?

We can help! Pharm-Olam currently holds memberships in the Medical CBRN Defense Consortium (MCDC). We also work with the DoD's Other Transaction Authority (OTA) and under Other Transactions (OTs).

Request A Posposal